LGND 88.29 Ligand Pharmaceuticals Inc $LGND Hit a 52 week

Argentina's Oil Play: Laredo Oil's Bold Venture Talk about shooting for the stars. Laredo Oil's second tête-à-tête with Santa Cruz Province's big wigs highlights their itch to rejuvenate Argentina's tired oil fields. For folks who know the nitty-gritty of oil, we're talking about the Golfo San Jorge Basin, a place where old dogs might learn new tricks thanks to that...

AST SpaceMobile's Unsteady Ground Let's dig into the wild ride AST SpaceMobile (NASDAQ: ASTS) has found itself on. These folks have been taking punches from every direction, from Wall Street's bean counters to hostile market winds. It all started when Scotiabank slapped them with a 'Sell' rating on January 6, 2026, pointing fingers at their faltering position against...

The dairy blends market, set to barrel towards USD 15.38 billion by 2035 according to Credence Research, isn't just a numbers game. It's a tug-of-war between different fats, regions, and regulations. For those betting on future market movements, this shouldn't be a passing glance. Rising from USD 9.97 billion in 2025, these figures suggest consistent waves rather than...

New Insights in Recovery with ARPwave Therapy Getting stuck in a rehab rut is not uncommon. That's where ARPwave therapy steps in, taking an innovative approach to healing by focusing on the nervous system's role in recovery. Props to Jeff Kessler from Maximum Health Physical Therapy for shedding light on this game-changing method during an insightful piece in...

Burger King's Hello Kitty® Move: Fad or Brilliant? Few things scream nostalgia like Hello Kitty® and a Burger King kids' meal. It's the kind of combo that makes you wonder if we're simply riding a wave of kawaii nostalgia or if this is a masterstroke tapping into a multi-generational goldmine. What's in the Box? Burger King isn't playing around. Starting October 20,...

Compassionate Expansion Reflecting Community Needs You talk to just about any family facing the heart-wrenching task of making decisions for a loved one's final farewell, and the story ain't pretty. Pricey packages, pressure to upgrade, and a constant side-eye wondering if they're getting the real deal. For Minnesota Cremation Services, though, this expansion is about...

AI Promises or Pipedreams? AppLovin Corporation finds itself in a bit of hot water, and if you've got skin in this game, you've probably felt the heat. So, what's stirring the pot? A class action lawsuit against AppLovin (NASDAQ: APP) for allegedly pulling the wool over investors' eyes with overstated claims about their generative AI tool. Class Action: Weighing the...

A Game Changer for Postpartum Recovery When it comes to childbirth, you think you've heard it all, but here's a twist—Allegheny Health Network (AHN) just swung the doors open on a clinic laser-focused on a very raw deal: third- and fourth-degree perineal lacerations. We're diving into new territory where one network sees the gap and jumps into action, calling in the...

Is ODP Getting a Raw Deal? Grab a cup of joe, because this is one of those sticky situations where the stakes are high, and the details are grimmer than last week's sales report. On August 19, 2026, Monteverde & Associates PC filed a lawsuit targeting the acquisition of The ODP Corporation by Atlas Holdings LLC, claiming the buyout price wasn't just low—it was roaringly...

A Cold Shower for Millrose Properties' Investors Investing in Millrose Properties, Inc. (NYSE: MRP) didn't quite pan out as some folks hoped. On the heels of Hunterbrook's report about dubious deals, the Company's stock tumbled 8.53%, smacking investors with a not-so-gentle reminder of market realities. Sure, stocks can dip and dive like a rollercoaster, but when it...

Editas Medicine's Upcoming Presentation Highlights Editas Medicine, Inc. (NASDAQ: EDIT), a trailblazer in gene editing, is excited to announce that it will present at the renowned European Society of Gene and Cell Therapy (ESGCT) Congress. The congress is set to occur from October 7 to October 10, making this a significant occasion for the company and the field of gene...

ICP DAS-BMP Showcases Medical Innovations at COMPAMED ICP DAS-BMP, a prominent manufacturer from Taiwan, is gearing up for the prestigious COMPAMED event taking place in Germany. This event, which draws significant attention from the medical device industry, showcases advancements in medical-grade thermoplastic polyurethane (TPU) materials. Focus on Low-Migration and...

Broadcom's Recent Performance and Growth Potential Broadcom Inc. has made headlines recently with its remarkable performance in the tech sector. Following a solid earnings report for the second quarter, this semiconductor leader has seen its stock, designated as AVGO, score a notable jump of nearly 19% year-to-date. This surge has been particularly impressive, as the...

InCarda Therapeutics Welcomes Dr. Myles Greenberg as CEO InCarda Therapeutics, a clinical-stage biopharmaceutical firm dedicated to developing cutting-edge treatments for cardiac arrhythmias, has appointed Dr. Myles Greenberg, MD, MBA, as its new Chief Executive Officer. Dr. Greenberg is set to lead the company as they work on their flagship product, an orally inhaled...

Understanding Jim Cramer's Perspective on Nvidia CNBC’s Jim Cramer hinted at a potential turning point for NVIDIA Corp. (NASDAQ: NVDA) after the stock reached $127. This could signal a bottom for the semiconductor giant after its recent setbacks. Market Dynamics: What Cramer Noted Cramer’s Observations According to Cramer, the $127 mark could indicate a pivotal moment...